Introduction
Myelodysplastic syndrome (MDS) is a hematopoietic stem cell disorder characterized by peripheral blood cytopenia, morphological abnormalities of bone marrow cells and frequent progression to acute leukemia. Although several cytogenetic abnormalities, such as deletion of chromosomes 5 and 7, have been known to associate with this heterogeneous disorder, little is known about what genetic change(s) are responsible for this disease. Several genetic changes, including expression of chimerical proteins due to chromosome translocations, have been found in MDS, [1] [2] [3] mostly in advanced cases. These abnormalities are also found in some de novo acute myelogenous leukemia (AML), suggesting that such genetic changes may be late events in MDS. In recent years, epigenetic changes, which do not alter primary structures of the genes but affect regulation of gene expression, have been recogCorrespondence: H Ohashi, The First Department of Internal Medicine, Nagoya University School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya, 466-8550, Japan; Fax: 81-52-744-2157 Received 19 July 1999; accepted 24 November 1999 nized as playing certain roles in hematological and non-hematological malignancies. [4] [5] [6] Hypermethylation of the regulatory sequences of tumor suppressor genes and consequent silencing of the gene could theoretically be equivalent to deletion or loss-of-function type of genetic mutations for tumorigenesis. In a previous study utilizing Southern blotting with a methylation-sensitive restriction enzyme, we reported that hypermethylation of the regulatory region of the p15 INK4B tumor suppressor gene is frequently observed in bone marrow cells of MDS patients, especially, although not exclusively, in the advanced stage of the disease. 7 Recent technical advances in studies of DNA methylation are the development of the bisulfite modification technique of DNA by Frommer et al, 8 and that of the methylation-specific PCR (MSP) method, based on the former, by Herman et al. 9 Cytosines are susceptible, while 5-methyl-cytosines are resistant to deamination and conversion to uracils by sodium bisulfite. Thus, the differences in methylation status in cytosines can be converted to those in primary structures of the DNA. Methylated-sequence-specific (M) primers and unmethylated-sequence-specific (U) primers can specifically amplify methylated and unmethylated alleles of the gene, respectively. An important advantage of this method in comparison to Southern blotting with methylation-sensitive restriction enzymes is its high sensitivity in detecting methylated alleles against the background of largely unmethylated genome. 10 Quesnel et al 11 examined bone marrow cells of 53 MDS patients by this method and found that most of them whose bone marrow contained more than 10% of blasts showed methylation of the p15 INK4B gene, while none with less than 10% of same had p15 INK4B methylation. These results suggest that it is the blasts that harbor hypermethylated allele of the p15 INK4B gene. In our previous study by Southern blotting, which is much less sensitive in detecting methylation than the MSP method, however, the bone marrow cells of an RA patient with few blasts in the bone marrow showed significant methylation of this gene. 7 Since not only the blasts but also the majority of the mature blood cells are considered to be of clonal origin in MDS, 12, 13 it is of interest whether only the blasts have p15 INK4B methylation, or whether cells that have differentiated into mature cells also harbor this epigenetic alteration. Another question is whether methylation of the p15 INK4B gene in hematologic cells in MDS patients is restricted to the MDS clone. This issue, which is generally taken for granted, could be of importance because unlike mutations, cytosine methylation is considered to be a possibly reversible phenomenon.
The present study aims to determine: (1) 
Materials and methods

Patients
We analyzed 23 patients with MDS, including 11 RA, two RARS, five RAEB, three RAEB-T, and two secondary acute myelogenous leukemia (sAML) evolved from MDS. One patient developed MDS after high-dose chemotherapy and subsequent autologous bone marrow transplantation for nonHodgkin's lymphoma. Seven of these patients were previously analyzed for p15 INK4B methylation by Southern blotting. 7 Characteristics of the patients are summarized in Table 1 .
Cell fractionation and DNA extraction
Aspiration and venipuncture obtained bone marrow (BM) and peripheral blood (PB), respectively, with informed consent of the patients. The mononuclear cells (MNCs) were separated from bone marrow aspirates by density gradient centrifugation on Ficoll-Paque (Pharmacia, Uppsala, Sweden). The PB-polymorphonuclear (PMN) fractions were separated from heparinized peripheral blood as described. 14 Briefly, 10 to 20 ml of heparinized blood was sedimentated through Ficoll-Paque, and mononuclear cells (MNCs) were removed from the interface layer. PB-PMNs were collected from the pellet by removing lysed erythrocytes after incubation in 17 mm Tris-NH 4 Cl buffer. High molecular genomic DNA from each fraction of hematologic cells and cell lines (HL60, ML1) was purified by the standard procedure with SDS-Proteinase K treatment and phenol extraction. 15 DNA was also extracted from individual 
Hematopoietic progenitor assay
BM-MNCs from MDS were incubated in RPMI with 20% fetal bovine serum (FBS) for 2 to 3 h in order to remove adherent cells, followed by 12 days culture in 1 ml of MethoCult GF H4434 (StemCell Technologies, Vancouver, Canada) containing methylcellulose in Iscove's MDEM, fetal bovine serum, bovine serum albumin (BSA), 2-mercapto-ethanol, l-glutamine, recombinant human erythropoietin (EPO), granulocytemacrophage colony-stimulating factor (GM-CSF), interleukin-3 (IL-3) and stem cell factor (SCF) in a 35-mm culture dish (Nunc, Naperville, IL, USA) at 37°C with fully humidified atmosphere of 5% CO 2 . Individual erythroid and nonerythroid colonies were picked up by hand with a micropipette, and DNA was extracted and resuspended in 20 l of TE buffer.
Bisulfite modification of DNA
DNA extracted from fractionated bone marrow, peripheral blood cells, or colonies was chemically modified by sodium bisulfite to convert all unmethylated (but not methylated) cytosines to uracils according to the method described by Herman et al, 9 using CpGenome DNA Modification kit (Oncor, Gaithersburg, MD, USA). The chemical modification was performed according to the manufacturer's instruction. We modified 500 ng of DNA obtained from BM-MNCs, PB-PMNs and cell lines and 4 l of 20 l DNA solution from each colony. Modified DNA from each colony was resuspended in 20 l of TE buffer. As controls to monitor efficiency of modification, DNA extracted from HL60 (p15
INK4B
-unmethylated) and ML1 (p15 INK4B -methylated) 7 was processed similarly.
MSP for the p15 INK4B gene
With the primer sets described by Herman et al, 9 the MSP for the p15 INK4B was performed. Each primer set recognizes the nucleotide sequences of methylated and unmethylated p15 INK4B gene promoter modified by sodium bisulfite, respectively, and PCR product can be seen only when methylated (or unmethylated) allele is present by M (or U) primer set. Thus, if the DNA sample contains both methylated and unmethylated p15 INK4B alleles, which is often the case with clinical samples, bands can be seen both on the M and the U lanes. The PCR reaction mixture, which was described by Quesnel et al, 11 contained 6.5 mmol/l MgCl 2 , 10 mmol/l Tris HCl, pH 9,50 mmol/l KCI, 0.1% Triton X100, 0.2 mg/l bovine serum albumin, dNTPs (each at 0.5 mm/l), 20 pmol of each primer, 5% dimethyl sulfoxide (DMSO), 1 U of Taq polymerase (Takara, Kyoto, Japan), and bisulfite modified DNA. Fifty nanograms of modified DNA from BM-MNCs were amplified for 40 cycles, while 2 l of those from each colony were amplified for 50 cycles. PCR products were directly loaded on to 3% NuSieve agarose gel (FMC Bioproducts, Rockland, MD, USA), electrophoresed, stained with ethidium bromide, and visualized under UV illumination. As positive and negative controls for modification and PCR, modified DNA extracted from HL60 and ML1 were analyzed. To con-firm the sensitivity of the MSP method, HL60 and ML1 cells were mixed at various ratios. We amplified 50 ng of modified DNA extracted from mixed cells for 50 cycles.
MSP for the HUMARA gene
We developed an MSP-based method for X-chromosomelinked clonality analysis, which is a modification of the HUM-ARA method described by Allen et al. 16 The detail is described elsewhere. 17 Briefly, the upstream methylated (M) and unmethylated (U) primers were set on the sequence of the human androgen receptor (HUMARA) gene, described by Allen et al to be differentially methylated on the active and inactive X-chromosomes, and the common downstream primer was located in the area without CpG dinucleotides. Between the upstream primer and the downstream primer lies the (CAG) repeat, the number of which is highly polymorphic. As the M and U primers for the p15 INK4B gene amplify the methylated and unmethylated p15 INK4B gene, respectively, the M and U primer sets (namely the upstream M primer and the downstream common primer, and the upstream U primer and the downstream common primer) for the HUMARA gene amplify the methylated (on the inactive X-chromosome) and unmethylated (on the active X-chromosome) alleles, respectively. When a single cell, or a cell population derived from a single cell such as a hematopoietic colony, from a female heterozygous for the HUMARA polymorphism, is examined by this method, the M primer set should produce one band while the U primer set should generate another band of a different size (Figure 1 ). If the cell population is polyclonal, both the M primer set and the U primer set produce two bands of similar intensity, respectively. A schematic representation of the band patterns predicted to be seen with monoclonal and polyclonal cell populations, in comparison with those by the conventional HUMARA assay, is shown in Figure 1 . Since a hematopoietic colony is considered to be of single-cell origin, each colony picked up should produce either A or B pattern, if contamination with neighboring cells is negligible (Figure 1 ).
Figure 1
A schematic representation of the band patterns by HUMARA-MSP. The methylated allele is shown as a bold line. The U and M primer sets for the HUMARA gene amplify the unmethylated (ie active) and methylated (ie inactive) allele, respectively. A cell which has methylated long (CAG) repeat allele of the HUMARA gene is named A-pattern, while that which has methylated short (CAG) repeat allele is named B-pattern.
In order to examine cells from single colonies and increase the sensitivity of the method, we employed a semi-nested, two-step strategy of amplification for HUMARA-MSP. Five microliters of bisulfite-modified DNA solution was added to 45 l of buffer (100 mmol/l Tris-HCl, 500 mmol/l KCI, 15 mm MgCl 2 ) containing the outer set of primers (for M and U amplification, respectively, 20 pmol/l each), dNTP and 1 U of Taq polymerase, and amplified for 35 cycles in a thermal cycler (Takara, Kyoto, Japan). One tenth of each reaction solution was added to the second reaction solution containing the inner, semi-nested primers (for M and U amplification, respectively, 20 pmol/l each) and amplified for further cycles. After the second reaction, each solution was separated by electrophoresis through 10% polyacrylamide gel and stained with ethidium bromide. On the basis of amplified band pattern, which reflects XCI pattern, each colony was determined to be either A-or B-pattern (Figure 1 ). In one patient whose numbers of CAG repeats of two alleles seemed to be very close (UPN 19), it was difficult to determine XCI patterns by the non-isotopic method we described above, because of the insufficient separation of two bands. In this case, we carried out second amplification for 35 cycles with the addition of ␣-32 P dCTP at 1 Ci/reaction. PCR products were separated on 6% denaturing polyacrylamide gels containing 7-M urea that should allow detection of one base difference. Then the dried gel was exposed to phosphorimaging plates (Imaging plate BASIII; Fuji Photo Film, Kanagawa, Japan), followed by analysis with a laser image analyzer (FUJIX BAS 2000; Fuji Photo Film).
Southern hybridization
Southern hybridization with a methylation-sensitive restriction enzyme for the p15 INK4B gene was performed as previously described. 7 Briefly, 5 g of DNA was digested with 20 U each of HindIII and Eco52I, a methylation-sensitive restriction enzyme, and separated through 0.7% agarose gel, transferred to a nylon membrane, hybridized to the ␣-32 P dCTP-labeled 
Results
Methylation status of the p15 INK4B gene in bone marrow mononuclear cells
We performed methylation analysis of the p15 INK4B gene by the MSP on the BM-MNC samples from the 23 MDS patients. Amplification bands with the unmethylated sequence-specific primer pair (p15-U primers) were detected in all samples, which probably reflects the existence of normal cells in all patients. Specific bands amplified with the methylated sequence-specific primer pair (p15-M primers) were observed in six (26%) of the patients (Table 1, Figure 2a) . Hypermethylation of the p15 INK4B gene was found mostly in the high-risk subtypes (RAEB, RAEB-T and sAML; 5/10,50%), and only one of the 13 low-risk patients (RA and RARS; 8%) showed p15 INK4B gene methylation. This result confirmed previous reports.
7,11 DNA obtained from PB-PMNs from 30 healthy volunteers and HL60 cell line showed amplification with only U primers, while DNA from MLI cell line showed M but not U bands (Figure 2a ). In the cell mixture experiment, methylation could be detected in 1% but not in 0.1% of ML1 cell line sample (Figure 2b ).
Methylation status of the p15
INK4B and HUMARA genes in hematopoietic colonies After 12-day culture in cytokine-supplied methylcellulose medium, BM-MNCs from 13 out of 23 MDS patients formed erythroid and/or non-erythroid colonies. The distinction between erythroid and non-erythroid colonies was made based on morphology determined under an inverted microscope. 18 As shown in Table 1 , two of the six patients with methylated BM-MNCs formed colonies, and of the 17 patients without the p15 INK4B gene methylation, 11 showed colony formation. (UPN 2 and 22) . p15-U and -M primer sets produce specific products, respectively. HL60 (p15-unmethylated) showed U band only and ML1 (p15-methylated) showed M band only. UPN 2, RA patient, has unmethylated p15 gene. In contrast, UPN 22 with sAML showed p15 methylation. (b) HL60 and ML1 cells were mixed at various ratios.
Leukemia
Among the 23 MDS patients analyzed, only two showed both p15 INK4B methylation and colony formation. One was UPN 1, with RA, whose BM-MNCs formed non-erythroid colonies only, and the other was UPN 19 with RAEB-T and both erythroid and non-erythroid colony formation. Both patients showed normal karyotype on cytogenetic analysis of the bone marrow cells. The individual colonies from these two patients were picked up by hand and subjected to MSP analyses. After DNA extraction and bisulfite modification, PCR with p15-M and P15-U primer sets was performed, respectively, to examine if any of these colonies had p15 INK4B gene methylation. In both patients, some colonies showed amplified bands with the p15-M primer set, indicating they actually had methylated the p15 INK4B gene. Simultaneous analysis by HUMARA-MSP was done for both patients to determine the XCI pattern of each colony. Both patients were heterozygous for HUMARA polymorphism, but one of them (UPN 19) showed a very small difference in the sizes of the two alleles, and we needed to employ an isotopic method to detect the difference. Representative results are shown in Figure 3 , and the results in the two patients are summarized in Table 2 . For UPN 19, whose HUMARA alleles had a very small size difference, the representative band pattern would be as below: due to the construction of the primers, the expected product size for the U primer set is 5 bp longer than from the M primer set. Presumably UPN 19 has one (CAG) repeat (ie 3 bp) difference between the two alleles. If so, when her long repeat allele is methylated (A-pattern), the band size produced from the U primer set would be 2 bp longer than from the M primer set, while if her short repeat allele is methylated (B-pattern), the size difference between the products from the U and M primer sets would be 8 bp. The actual band patterns are compatible with these presumed results ( Figure 3B ).
We picked up 41 non-erythroid colonies from the progenitor assay dishes for the RA patient (UPN 1), and 26 erythroid and 27 non-erythroid colonies from the RAEB-T patient (UPN 19). For p15-MSP in colonies from UPN 1, 21 of 41 nonerythroid colonies showed U bands only (p15-U colonies), eight showed M bands only (p15-M colonies), six showed both U and M bands, and six did not show either M or U bands (Table 2A) . On simultaneous HUMARA-MSP analysis, 29 colonies were the A-pattern of XCI, five showed B-pattern The expecting product size from the U primer set is 5 bp longer than that from the M primer set. Since the patient has only one (CAG) repeat difference for HUMARA polymorphism, presumably, when her long (CAG) repeat allele is methylated (A-pattern), the size of the U band would be 2 bp longer than that of the M band, while when her short (CAG) repeat allele is methylated (B-pattern), the U band size would be 8 bp longer than the M band size.
and no bands were detectable in seven colonies. The failure to detect any PCR products either by p15-or HUMARA-MSP may well be due to the small amount of DNA utilized, as we and others experienced in similar experiments. [18] [19] [20] In p15-U colonies, the numbers of colonies showing A-pattern and Bpattern were 13/21 and 4/21, respectively, while all p15-M colonies were the A-pattern of XCI except for one colony with no detectable HUMARA-MSP bands.
In both erythroid and non-erythroid colonies from UPN 19, there were four types of colonies (U band only, M band only, both U and M bands, and no detectable band colonies) as shown in Table 2B . Among seven p15-U colonies in 27 nonerythroid colonies, five showed the A-pattern of XCI, one showed B-pattern. On the other hand, in 14 colonies with M band, 12 were the A-pattern of XCI and none was B-pattern. Among erythroid colonies, 15 colonies showed U band only, and 11 of those were A-pattern, four were B-pattern. For the six p15-M colonies, five showed the A-pattern and none the B-pattern of XCI.
Methylation status of the p15 INK4B gene in peripheral blood cells
Peripheral blood samples were available for 10 of the 23 patients, and PB-PMN fractions were analyzed for p15 INK4B gene methylation by the MSP. PB-PMNs are the fraction of the peripheral blood cells, in which polymorphonuclear granulocytes can be separated with 97% purity, when assessed with samples without blasts.
14 As shown in Figure 4a , in all four patients whose BM-MNCs had p15 INK4B methylation, the PB-PMNs were positive for p15 INK4B methylation, while the PB-PMNs of all six patients with p15 INK4B -unmethylated BMMNCs did not show p15 INK4B methylation. In the three patients with PB-PMNs positive for p15 INK4B methylation, blasts were present in the peripheral blood (15-29%, Table 3 ). The observations and the fact that the MSP is a sensitive method for detection may indicate that the p15 INK4B methylation in PBPMNs is the result of blast cells in the PB-PMN fractions. However, one RA patient (UPN 1) with no blast in her PB showed p15 INK4B methylation in PB-PMN. Moreover, the PBPMNs of one of these patients (UPN 22) obtained earlier when her disease was in RA stage (blasts were not present in this peripheral blood) also showed p15 INK4B methylation (Table 3) . To assess the methylation status of the p15 INK4B gene in PBPMNs more quantitatively, we performed Southern blot hybridization for one patient (UPN 19). Methylation intensity 7 of PB-PMNs obtained from this patient was 21% (Figure 4) . She had 15% of blasts in her PB (Table 3) , and the percentage of blasts in PB-PMN fraction is expected to be much lower than that in the unfractionated PB cells. Thus, the Southern blot result confirms that not only the blasts, but also at least some of the granulocytes, have methylated the p15 INK4B gene.
Discussion
The importance of inactivation of tumor suppressor genes by methylation of their promoters has recently been acknowl- Table 3 p15 gene methylation status in BM-MNCs and PB-PMNs
